The grant supports research that will contribute to the overall understanding of vaccine safety. This research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as:
1) physiological and immunological responses to vaccines and vaccine components,
2) how genetic variations affect immune/physiological responses that may impact vaccine safety,
3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, or
4) the application of genomic/molecular technologies to improve knowledge of vaccine safety
This grant is available in both the R01 and R21 scheme. See more information here:
http://grants.nih.gov/grants/guide/pa-files/PA-08-256.html (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-08-257.html (R21)
R01 = more money, but requires extensive preliminary research and expertise
R21 = less money, more exploratory and "risky" research
The deadline for this application is 8 January 2012. The R01 is for up to 5 years of funding, with no formal budget limit. The R21 is worth $275,000 over 2 years.
TropMed Sponsored Research Funding Opportunities: this blog is designed to alert TropMed researchers to funding opportunities to support their research. The Research Administration Unit of the Office of Research Services (ORS) is here to help staff members with all application, grant management, and post-grant processes. Please contact Mr. Paul Adams or Mr. Oiko Tacusalme on ext. 1332 for more information, or to express interest in any of these grant opportunities.
